Name (Synonyms) | Correlation |
---|
Name (Synonyms) | Correlation |
---|
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Study hypothesis: Non-invasive positive pressure ventilation delivered by helmet will reduce 28-day all-cause mortality in patients with suspected or confirmed severe COVID-19 pneumonia and acute hypoxemic respiratory failure
Description: all cause mortality
Measure: 28-day all-cause mortality Time: 28 days from randomizationDescription: endotracheal intubation
Measure: Requirement for endotracheal intubation within 28 days Time: 28 days from randomizationDescription: ICU death
Measure: ICU mortality Time: 180 days from randomizationDescription: hospital death
Measure: Hospital mortality Time: 180 days from randomizationDescription: days not in ICU
Measure: ICU free days at day 28 Time: 28 days from randomizationDescription: days without ventilator support
Measure: Ventilator free days at day 28 Time: 28 days from randomizationDescription: days without renal replacement therapy received
Measure: Renal replacement therapy free days at day 28 Time: 28 days from randomizationDescription: days without vasopressor support
Measure: Vasopressor free days at day 28 Time: 28 days from randomizationDescription: presence of pressure ulcers
Measure: Skin pressure ulcers Time: 28 days from randomizationDescription: tolerance to intervention
Measure: Tolerance of helmet (>1-hour use) Time: 28 days from randomizationDescription: vital status
Measure: 180-day mortality Time: 180 days from randomizationDescription: The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
Measure: 180-day 5-level EQ-5D version Time: 180 days from randomization